161 related articles for article (PubMed ID: 35899035)
1. Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention.
Oh SL; Zhou M; Chin EWM; Amarnath G; Cheah CH; Ng KP; Kandiah N; Goh ELK; Chiam KH
Front Digit Health; 2022; 4():875895. PubMed ID: 35899035
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers.
Sapkota S; Huan T; Tran T; Zheng J; Camicioli R; Li L; Dixon RA
Front Aging Neurosci; 2018; 10():296. PubMed ID: 30333744
[No Abstract] [Full Text] [Related]
3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
4. Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis.
Ogonowski N; Salcidua S; Leon T; Chamorro-Veloso N; Valls C; Avalos C; Bisquertt A; Rentería ME; Orellana P; Duran-Aniotz C
Front Aging Neurosci; 2021; 13():807764. PubMed ID: 35095478
[TBL] [Abstract][Full Text] [Related]
5. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
6. Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data.
Shigemizu D; Akiyama S; Higaki S; Sugimoto T; Sakurai T; Boroevich KA; Sharma A; Tsunoda T; Ochiya T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Nov; 12(1):145. PubMed ID: 33172501
[TBL] [Abstract][Full Text] [Related]
7. Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning.
Li Q; Wu X; Xu L; Chen K; Yao L;
Front Comput Neurosci; 2017; 11():117. PubMed ID: 29375356
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
[TBL] [Abstract][Full Text] [Related]
9. Altered DNA methylome profiles of blood leukocytes in Chinese patients with mild cognitive impairment and Alzheimer's disease.
Wu S; Yang F; Chao S; Wang B; Wang W; Li H; Yu L; He L; Li X; Sun L; Qin S
Front Genet; 2023; 14():1175864. PubMed ID: 37388929
[No Abstract] [Full Text] [Related]
10. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
[TBL] [Abstract][Full Text] [Related]
11. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
[TBL] [Abstract][Full Text] [Related]
12. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
13. Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease.
Pfeil J; Hoenig MC; Doering E; van Eimeren T; Drzezga A; Bischof GN;
Neurobiol Aging; 2021 Oct; 106():119-129. PubMed ID: 34284259
[TBL] [Abstract][Full Text] [Related]
14. Gaussian Discriminant Analysis for Optimal Delineation of Mild Cognitive Impairment in Alzheimer's Disease.
Fang C; Li C; Cabrerizo M; Barreto A; Andrian J; Rishe N; Loewenstein D; Duara R; Adjouadi M
Int J Neural Syst; 2018 Oct; 28(8):1850017. PubMed ID: 29793369
[TBL] [Abstract][Full Text] [Related]
15. The Effects of CSF Neurogranin and
Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
[TBL] [Abstract][Full Text] [Related]
16. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
17. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
[TBL] [Abstract][Full Text] [Related]
18. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
19. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
[TBL] [Abstract][Full Text] [Related]
20. Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage.
Poil SS; de Haan W; van der Flier WM; Mansvelder HD; Scheltens P; Linkenkaer-Hansen K
Front Aging Neurosci; 2013; 5():58. PubMed ID: 24106478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
